US2013324759A1PendingUtilityA1

Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers

Assignee: MAMELAK MORTIMERPriority: Sep 22, 2000Filed: May 20, 2013Published: Dec 5, 2013
Est. expirySep 22, 2020(expired)· nominal 20-yr term from priority
A61P 43/00A61P 5/00A61P 9/00A61P 3/10A61P 39/06A61P 9/10A61P 5/06A61P 39/00A61P 37/06A61P 25/04A61P 25/36A61P 25/32A61P 25/22A61P 25/30A61P 25/00A61P 25/28A61P 25/24A61P 29/00A61P 25/20A61P 25/16C07C 233/49A61P 1/00C07C 229/24C07C 229/36C07C 69/67A61P 23/00C07H 13/04C07C 229/22C07C 69/675A61P 1/04C07C 233/47
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, or can target specific organs.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A compound of the formula (II):
   (R 1 O(CH 2 ) 3 CO 2 ) m (ROC(O)(CH 2 ) 3 OC(O)) q —(X)—(Y) n —(Z) n —(CO 2 (CH 2 ) 3 CO 2 R) p (O 2 C(CH 2 ) 3 OR′) k   (II)
   wherein R′ is H or a hydroxyl-protecting group, R is H, (C 1 -C 4 )alkyl or benzyl, X and Z are each residues of a hydroxy group-containing amino acid or a bis(carboxy)amino acid, Y is a moiety covalently linking X and Z, n is 0-1, m and k are 0 to the number of available hydroxy groups on the amino acids X and Z; q and p are 0 to the number of available CO 2  groups on amino acids X and Z, with the proviso that both m and q and both p and k are not zero, or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2013324759A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.